Tenetin M Sustained-Release Tablet 20/1000 mg

Adult dose

This medication is generally administered once a day with the evening meal, The 20/1000 mg sustained-release tablet is taken once daily, 1 tablet at a time. The 10/750 mg or 10/500 mg sustained-release tablets are taken once daily, 2 tablets at the same time. The initial dose should provide 20 mg of teneligliptin once a day and the existing dose of metformin. The maximum recommended daily dose is 20 mg of teneligliptin and sustained-release

This medication may very rarely cause a serious condition called lactic acidosis. Lactic acidosis is a dangerous condition resulting from excessive accumulation of lactic acid in the body, which can sometimes lead to death. Caution is advised when taking this medication with insulin or other diabetes medications, as severe hypoglycemia may occur. Patients with moderate to severe renal impairment, heart failure, acute myocardial infarction, severe infections, etc. should not be administered this medication. Patients scheduled for examinations using iodinated contrast media should stop taking this medication 48 hours prior to the examination and resume only after confirming normal kidney function post-examination. It is advisable for women who are pregnant or may become pregnant to avoid taking this medication. This medication can cause hypoglycemic symptoms, so patients at high risk of hypoglycemia should be cautious during irregular meals, excessive exercise, or use of other diabetes medications. Severe side effects such as acute pancreatitis may occur, so immediate medical attention should be sought if severe abdominal pain or vomiting persists. This medication is not to be used in patients with liver dysfunction and should be consulted immediately with a doctor if symptoms such as interstitial pneumonia, skin rash, or similar occur. Regular monitoring of kidney function, blood tests, and vitamin B12 levels is important during treatment. Alcohol consumption may increase the risk of side effects from this medication, so drinking should be avoided during treatment. Elderly patients are at higher risk of renal impairment and require dosage adjustment and regular monitoring. In the case of overdose, appropriate treatment including gastric decontamination and ECG monitoring is required, and in patients with poor kidney function, dialysis may be helpful. This medication should be kept out of reach of children, and transferring it to other containers should be avoided. Lastly, it is important to be aware of hypoglycemic symptoms and symptoms of lactic acidosis while taking this medication, and to inform medical personnel if any abnormal symptoms occur.

Serious side effects

Hypoglycemia, urticaria, severe swelling (edema), chest tightness, shortness of breath, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, severe skin reactions, difficulty breathing or shortness of breath, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice)

Mild side effects

• Constipation
• dizziness
• abdominal bloating
• abdominal discomfort
• nausea
• abdominal pain
• flatulence
• stomatitis
• gastric polyps
• colon polyps

This medication should be stored in a tightly closed container to prevent air from entering, and it is best to store it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness for an extended period.

Appearance

Pink oval shaped sustained-release film-coated tablet

Package unit

Bottle - 30 tablets/bottle